Global Aplastic Anemia Therapeutics Pipeline Report 2016 - Review of 8 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Aplastic Anemia - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Aplastic Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Aplastic Anemia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Aplastic Anemia Overview
  3. Therapeutics Development
  4. Pipeline Products for Aplastic Anemia - Overview
  5. Pipeline Products for Aplastic Anemia - Comparative Analysis
  6. Aplastic Anemia - Therapeutics under Development by Companies
  7. Aplastic Anemia - Therapeutics under Investigation by Universities/Institutes
  8. Aplastic Anemia Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Aplastic Anemia - Products under Development by Companies
  13. Aplastic Anemia - Products under Investigation by Universities/Institutes
  14. Aplastic Anemia - Companies Involved in Therapeutics Development
  • 3SBio Inc.
  • Acceleron Pharma, Inc.
  • Amgen Inc.
  • BioLineRx, Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pluristem Therapeutics Inc.
  • Regen BioPharma, Inc.

For more information visit http://www.researchandmarkets.com/research/8k78zj/aplastic_anemia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematological Drugs